Table 2.
Univariate analysis of predictive factors of post-operative endocrine insufficiency
| Variables | Presence of new post-operative endocrine insufficiency (n = 28)a | Absence of new post-operative endocrine insufficiency (n = 150)a | p-value |
|---|---|---|---|
| Gender, N (%) | |||
| Female | 15 (54) | 79 (53) | 0.927 |
| Male | 13 (46) | 71 (47) | |
| BMI, kg/m2 (range) | 25.4 ± 3.5 | 27.7 ± 7.1 | 0.282 |
| Pancreaticoduodenectomy, N (%) | 19 (68) | 104 (70) | 0.799 |
| Malignant pathology, N (%) | 19 (73) | 91 (72) | 0.929 |
| Partial gastrectomy, N (%) | 12 (46) | 53 (38) | 0.410 |
| Location, tail N (%) | 4 (15) | 19 (13) | 0.795 |
| Pathologic presence of pancreatitis, N (%) | 10 (38) | 39 (28) | 0.287 |
| Neoadjuvant chemotherapy, N (%) | 1 (4) | 12 (8) | 0.408 |
| Adjuvant chemotherapy, N (%) | 18 (64) | 69 (49) | 0.138 |
| Neoadjuvant radiation therapy, N (%) | 1 (4) | 12 (8) | 0.408 |
| Adjuvant radiation therapy, N (%) | 15 (54) | 48 (34) | 0.048 |
a
Due to missing data points, percentages are based upon n of available data points.